238 related articles for article (PubMed ID: 24885011)
21. Alteration of Human Papillomavirus Type 16 Genetic and Epigenetic Profiles in Cervical Cancer Patients Is Indicative of Poor Disease Prognosis: A Cohort Analysis.
Dutta S; Singh RK; Mandal RK; Roychoudhury S; Basu P; Panda CK
Int J Gynecol Cancer; 2016 May; 26(4):750-7. PubMed ID: 27051049
[TBL] [Abstract][Full Text] [Related]
22. The application of BMRT-HPV viral load to secondary screening strategies for cervical cancer.
Duan L; Du H; Wang C; Huang X; Qu X; Shi B; Liu Y; Zhang W; Duan X; Wei L; Belinson JL; Wu R
PLoS One; 2020; 15(5):e0232117. PubMed ID: 32357165
[TBL] [Abstract][Full Text] [Related]
23. Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population.
Mirabello L; Sun C; Ghosh A; Rodriguez AC; Schiffman M; Wentzensen N; Hildesheim A; Herrero R; Wacholder S; Lorincz A; Burk RD
J Natl Cancer Inst; 2012 Apr; 104(7):556-65. PubMed ID: 22448030
[TBL] [Abstract][Full Text] [Related]
24. Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007.
Alemany L; de Sanjosé S; Tous S; Quint W; Vallejos C; Shin HR; Bravo LE; Alonso P; Lima MA; Guimerà N; Klaustermeier J; Llombart-Bosch A; Kasamatsu E; Tatti SA; Felix A; Molina C; Velasco J; Lloveras B; Clavero O; Lerma E; Laco J; Bravo IG; Guarch R; Pelayo A; Ordi J; Andújar M; Sanchez GI; Castellsagué X; Muñoz N; Bosch FX;
Int J Cancer; 2014 Jul; 135(1):88-95. PubMed ID: 24382655
[TBL] [Abstract][Full Text] [Related]
25. Association between human papillomavirus (HPV) 16, HPV18, and other HR-HPV viral load and the histological classification of cervical lesions: Results from a large-scale cross-sectional study.
Wu Z; Qin Y; Yu L; Lin C; Wang H; Cui J; Liu B; Liao Y; Warren D; Zhang X; Chen W
J Med Virol; 2017 Mar; 89(3):535-541. PubMed ID: 27464021
[TBL] [Abstract][Full Text] [Related]
26. Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16.
Louvanto K; Franco EL; Ramanakumar AV; Vasiljević N; Scibior-Bentkowska D; Koushik A; Cuzick J; Coutlée F; Lorincz AT;
Int J Cancer; 2015 Mar; 136(6):E638-45. PubMed ID: 25203794
[TBL] [Abstract][Full Text] [Related]
27. Analysis of human papillomavirus type 18 load and integration status from low-grade cervical lesion to invasive cervical cancer.
Cheung JL; Cheung TH; Ng CW; Yu MY; Wong MC; Siu SS; Yim SF; Chan PK
J Clin Microbiol; 2009 Feb; 47(2):287-93. PubMed ID: 19036939
[TBL] [Abstract][Full Text] [Related]
28. Identification of reliable biomarkers of human papillomavirus 16 methylation in cervical lesions based on integration status using high-resolution melting analysis.
Liu L; Ying C; Zhao Z; Sui L; Zhang X; Qian C; Wang Q; Chen L; Guo Q; Wu J
Clin Epigenetics; 2018; 10():10. PubMed ID: 29410710
[TBL] [Abstract][Full Text] [Related]
29. Impact of viral and host DNA methylations on HPV16-related cervical cancer pathogenesis.
Sen S; Mandal P; Bhattacharya A; Kundu S; Roy Chowdhury R; Mondal NR; Chatterjee T; Chakravarty B; Roy S; Sengupta S
Tumour Biol; 2017 May; 39(5):1010428317699799. PubMed ID: 28459195
[TBL] [Abstract][Full Text] [Related]
30. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
Song F; Du H; Wang C; Huang X; Wu R;
PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
[TBL] [Abstract][Full Text] [Related]
31. Management of high-risk HPV-positive women for detection of cervical (pre)cancer.
Luttmer R; De Strooper LM; Steenbergen RD; Berkhof J; Snijders PJ; Heideman DA; Meijer CJ
Expert Rev Mol Diagn; 2016 Sep; 16(9):961-74. PubMed ID: 27459506
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papillomavirus positive women: A prospective screening cohort study.
Dong L; Wang MZ; Zhao XL; Feng RM; Hu SY; Zhang Q; Smith JS; Qiao YL; Zhao FH
Gynecol Oncol; 2018 Jan; 148(1):103-110. PubMed ID: 29169614
[TBL] [Abstract][Full Text] [Related]
33. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
34. Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women.
Clarke MA; Gradissimo A; Schiffman M; Lam J; Sollecito CC; Fetterman B; Lorey T; Poitras N; Raine-Bennett TR; Castle PE; Wentzensen N; Burk RD
Clin Cancer Res; 2018 May; 24(9):2194-2202. PubMed ID: 29420222
[No Abstract] [Full Text] [Related]
35. Methylation of human papillomavirus Type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR.
Jacquin E; Baraquin A; Ramanah R; Carcopino X; Morel A; Valmary-Degano S; Bravo IG; de Sanjosé S; Riethmuller D; Mougin C; Prétet JL
J Clin Microbiol; 2013 Oct; 51(10):3207-15. PubMed ID: 23863566
[TBL] [Abstract][Full Text] [Related]
36. [Viral load, genomic integration frequency of human papillomavirus 16 in cervical cancer and precancerous lesions].
Li Y; Xiang Y; Zhang RF; Cai YP; Yang Y; Cheng XM; Zhu BL
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(13):906-10. PubMed ID: 21600119
[TBL] [Abstract][Full Text] [Related]
37. hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis.
de Wilde J; Kooter JM; Overmeer RM; Claassen-Kramer D; Meijer CJ; Snijders PJ; Steenbergen RD
BMC Cancer; 2010 Jun; 10():271. PubMed ID: 20534141
[TBL] [Abstract][Full Text] [Related]
38. Integrated HPV genomes tend to integrate in gene desert areas in the CaSki, HeLa, and SiHa cervical cancer cell lines.
Diao MK; Liu CY; Liu HW; Li JT; Li F; Mehryar MM; Wang YJ; Zhan SB; Zhou YB; Zhong RG; Zeng Y
Life Sci; 2015 Apr; 127():46-52. PubMed ID: 25747255
[TBL] [Abstract][Full Text] [Related]
39. Quantitative real-time polymerase chain reaction analysis of the type distribution, viral load, and physical status of human papillomavirus in liquid-based cytology samples from cervical lesions.
Yoshida T; Sano T; Kanuma T; Owada N; Sakurai S; Fukuda T; Nakajima T
Int J Gynecol Cancer; 2008; 18(1):121-7. PubMed ID: 17506843
[TBL] [Abstract][Full Text] [Related]
40. Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy.
Brandsma JL; Sun Y; Lizardi PM; Tuck DP; Zelterman D; Haines GK; Martel M; Harigopal M; Schofield K; Neapolitano M
Virology; 2009 Jun; 389(1-2):100-7. PubMed ID: 19443004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
